N23 (Neggram 1 GM)
Generic Name: nalidixic acid
Pill with imprint N23 is Yellow, Elliptical/Oval and has been identified as Neggram 1 GM. It is supplied by Sanofi-Synthelabo Inc.
NegGram is used in the treatment of bladder infection; prevention of bladder infection and belongs to the drug classes quinolones, urinary anti-infectives. Risk cannot be ruled out during pregnancy. NegGram 1 GM is not a controlled substance under the Controlled Substances Act (CSA).
Images for N23
Neggram
- Generic Name
- nalidixic acid
- Imprint
- N23
- Strength
- 1 GM
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Quinolones, Urinary anti-infectives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sanofi-Synthelabo Inc
- National Drug Code (NDC)
- 00024-1323 (Discontinued)
Related images for "N23"
More about NegGram (nalidixic acid)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (3)
- Drug images
- Drug class: quinolones
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.